pmc-enju-pas Home  

PMC:3586680 / 15852-16273 JSONTXT 21 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T8540 0-3 NN denotes p53
T8541 4-11 NN denotes mutants
T8542 12-15 VB denotes are
T8543 16-26 VB denotes considered
T8544 27-29 IN denotes as
T8545 30-41 JJ denotes unfavorable
T8546 42-49 NN denotes factors
T8547 50-53 IN denotes for
T8548 54-57 DT denotes the
T8549 58-71 NN denotes effectiveness
T8550 72-74 IN denotes in
T8551 75-87 NN denotes radiotherapy
T8552 88-91 CC denotes and
T8553 92-95 NN denotes TMZ
T8554 96-105 NN denotes treatment
T8555 106-108 IN denotes in
T8556 109-115 NN denotes glioma
T8557 116-121 NN denotes cells
T8558 122-123 -LRB- denotes (
T8559 123-130 NN denotes Gjerset
T8560 131-133 FW denotes et
T8561 134-137 FW denotes al.
T8562 137-138 -COMMA- denotes ,
T8563 139-143 CD denotes 1995
T8564 143-144 -COLON- denotes ;
T8565 145-151 NNP denotes Hirose
T8566 152-154 FW denotes et
T8567 155-158 FW denotes al.
T8568 158-159 -COMMA- denotes ,
T8569 160-164 CD denotes 2001
T8570 164-165 -COLON- denotes ;
T8571 166-175 NNP denotes Squatrito
T8572 176-178 FW denotes et
T8573 179-182 FW denotes al.
T8574 182-183 -COMMA- denotes ,
T8575 184-188 CD denotes 2010
T8576 188-189 -COLON- denotes ;
T8577 190-196 NNP denotes Blough
T8578 197-199 FW denotes et
T8579 200-203 FW denotes al.
T8580 203-204 -COMMA- denotes ,
T8581 205-209 CD denotes 2011
T8582 209-210 -RRB- denotes )
T8583 212-216 NN denotes Loss
T8584 217-219 IN denotes of
T8585 220-230 JJ denotes functional
T8586 231-234 NN denotes p53
T8587 235-242 VB denotes confers
T8588 243-254 NN denotes sensitivity
T8589 255-257 TO denotes to
T8590 258-261 NN denotes TMZ
T8591 262-264 IN denotes in
T8592 265-271 NN denotes glioma
T8593 272-277 NN denotes cells
T8594 277-278 -COMMA- denotes ,
T8595 279-286 IN denotes whereas
T8596 287-291 JJ denotes wild
T8597 292-296 NN denotes type
T8598 297-300 NN denotes p53
T8599 301-310 VB denotes increases
T8600 311-314 DT denotes the
T8601 315-318 NN denotes TMZ
T8602 319-329 NN denotes resistance
T8603 330-331 -LRB- denotes (
T8604 331-337 NNP denotes Blough
T8605 338-340 FW denotes et
T8606 341-344 FW denotes al.
T8607 344-345 -COMMA- denotes ,
T8608 346-350 CD denotes 2011
T8609 350-351 -RRB- denotes )
T8610 351-354 NN denotes . p
T8611 354-361 NN denotes 53 muta
T8612 361-367 VB denotes nts re
T8613 367-370 NN denotes duc
T8614 370-381 NN denotes e TMZ sensi
T8615 381-383 IN denotes ti
T8616 383-390 NN denotes vity in
T8617 391-392 -LRB- denotes g
T8618 392-398 NNP denotes liomas
T8619 399-401 FW denotes (B
T8620 401-404 FW denotes lou
T8621 404-405 -COMMA- denotes g
T8622 405-409 CD denotes h et
T8623 410-411 -RRB- denotes a
R5812 T8541 T8540 arg1Of mutants,p53
R5813 T8541 T8542 arg1Of mutants,are
R5814 T8541 T8543 arg2Of mutants,considered
R5815 T8543 T8542 arg2Of considered,are
R5816 T8543 T8544 arg1Of considered,as
R5817 T8543 T8555 arg1Of considered,in
R5818 T8546 T8544 arg2Of factors,as
R5819 T8546 T8545 arg1Of factors,unfavorable
R5820 T8546 T8547 arg1Of factors,for
R5821 T8549 T8547 arg2Of effectiveness,for
R5822 T8549 T8548 arg1Of effectiveness,the
R5823 T8549 T8550 arg1Of effectiveness,in
R5824 T8551 T8552 arg1Of radiotherapy,and
R5825 T8553 T8552 arg2Of TMZ,and
R5826 T8554 T8550 arg2Of treatment,in
R5827 T8554 T8551 arg1Of treatment,radiotherapy
R5828 T8554 T8553 arg1Of treatment,TMZ
R5829 T8557 T8555 arg2Of cells,in
R5830 T8557 T8556 arg1Of cells,glioma
R5831 T8557 T8558 arg1Of cells,(
R5832 T8559 T8560 arg1Of Gjerset,et
R5833 T8559 T8561 arg1Of Gjerset,al.
R5834 T8559 T8562 arg1Of Gjerset,","
R5835 T8562 T8558 arg2Of ",",(
R5836 T8562 T8564 arg1Of ",",;
R5837 T8562 T8570 arg1Of ",",;
R5838 T8563 T8562 arg2Of 1995,","
R5839 T8565 T8564 arg2Of Hirose,;
R5840 T8565 T8566 arg1Of Hirose,et
R5841 T8565 T8567 arg1Of Hirose,al.
R5842 T8565 T8568 arg1Of Hirose,","
R5843 T8569 T8568 arg2Of 2001,","
R5844 T8571 T8570 arg2Of Squatrito,;
R5845 T8571 T8572 arg1Of Squatrito,et
R5846 T8571 T8573 arg1Of Squatrito,al.
R5847 T8571 T8574 arg1Of Squatrito,","
R5848 T8571 T8576 arg1Of Squatrito,;
R5849 T8575 T8574 arg2Of 2010,","
R5850 T8577 T8576 arg2Of Blough,;
R5851 T8577 T8578 arg1Of Blough,et
R5852 T8577 T8579 arg1Of Blough,al.
R5853 T8577 T8580 arg1Of Blough,","
R5854 T8581 T8580 arg2Of 2011,","
R5855 T8582 T8558 arg3Of ),(
R5856 T8583 T8584 arg1Of Loss,of
R5857 T8583 T8587 arg1Of Loss,confers
R5858 T8586 T8584 arg2Of p53,of
R5859 T8586 T8585 arg1Of p53,functional
R5860 T8587 T8589 arg1Of confers,to
R5861 T8587 T8591 arg1Of confers,in
R5862 T8587 T8595 arg1Of confers,whereas
R5863 T8588 T8587 arg2Of sensitivity,confers
R5864 T8590 T8589 arg2Of TMZ,to
R5865 T8593 T8591 arg2Of cells,in
R5866 T8593 T8592 arg1Of cells,glioma
R5867 T8595 T8594 arg1Of whereas,","
R5868 T8598 T8596 arg1Of p53,wild
R5869 T8598 T8597 arg1Of p53,type
R5870 T8598 T8599 arg1Of p53,increases
R5871 T8599 T8595 arg2Of increases,whereas
R5872 T8602 T8599 arg2Of resistance,increases
R5873 T8602 T8600 arg1Of resistance,the
R5874 T8602 T8601 arg1Of resistance,TMZ
R5875 T8602 T8603 arg1Of resistance,(
R5876 T8602 T8612 arg2Of resistance,nts re
R5877 T8602 T8615 arg1Of resistance,ti
R5878 T8604 T8603 arg2Of Blough,(
R5879 T8604 T8605 arg1Of Blough,et
R5880 T8604 T8606 arg1Of Blough,al.
R5881 T8604 T8607 arg1Of Blough,","
R5882 T8608 T8607 arg2Of 2011,","
R5883 T8609 T8603 arg3Of ),(
R5884 T8611 T8610 arg1Of 53 muta,. p
R5885 T8611 T8612 arg1Of 53 muta,nts re
R5886 T8614 T8612 arg3Of e TMZ sensi,nts re
R5887 T8614 T8613 arg1Of e TMZ sensi,duc
R5888 T8616 T8615 arg2Of vity in,ti
R5889 T8616 T8617 arg1Of vity in,g
R5890 T8618 T8617 arg2Of liomas,g
R5891 T8618 T8619 arg1Of liomas,(B
R5892 T8618 T8620 arg1Of liomas,lou
R5893 T8618 T8621 arg1Of liomas,g
R5894 T8622 T8621 arg2Of h et,g
R5895 T8623 T8617 arg3Of a,g